Acumen Pharmaceuticals, Inc. 10-Q filing
Filed 2026-05-12 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001628280-26-034204
- Form type
- 10-Q
- CIK
- 0001576885
- Primary document
- https://www.sec.gov/Archives/edgar/data/1576885/000162828026034204/abos-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Acumen Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-21.1M | - | - |
| Net Income | $-20.7M | - | - |
| Eps Basic | -0.33 | - | - |
| Eps Diluted | -0.33 | - | - |
| Cash And Equivalents | $51.8M | - | - |
| Total Assets | $133.6M | - | - |
| Total Liabilities | $46.2M | - | - |
| Shareholders Equity | $87.5M | - | - |
| Operating Cash Flow | $-24.1M | - | - |